Literature DB >> 19252935

Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations.

Tatiana Fancello1, Andrea Dardis, Camillo Rosano, Patrizia Tarugi, Barbara Tappino, Stefania Zampieri, Elisa Pinotti, Fabio Corsolini, Simona Fecarotta, Adele D'Amico, Maja Di Rocco, Graziella Uziel, Sebastiano Calandra, Bruno Bembi, Mirella Filocamo.   

Abstract

Niemann-Pick C, the autosomal recessive neuro-visceral disease resulting from a failure of cholesterol trafficking within the endosomal-lysosomal pathway, is due to mutations in NPC1 or NPC2 genes. We characterized 34 unrelated patients including 32 patients with mutations in NPC1 gene and two patients in NPC2 gene. Overall, 33 distinct genotypes were encountered. Among the 21 unpublished NPC1 alleles, 15 were due to point mutations resulting in 13 codon replacements (p.C100S, p.P237L, p.R389L, p.L472H, p.Y634C, p.S636F, p.V780G, p.Q921P, p.Y1019C, p.R1077Q, p.L1102F, p.A1187V, and p.L1191F) and in two premature stop codons (p.R934X and p.Q447X); a new mutant carried two in cis mutations, p.[L648H;M1142T] and four other NPC1 alleles were small deletions/insertions leading both to frame shifts and premature protein truncations (p.C31WfsX26, p.F284LfsX26, p.E1188fsX54, and p.T1205NfsX53). Finally, the new intronic c.464-2A>C change at the 3' acceptor splice site of intron 4 affected NPC1 messenger RNA processing. We also found a new NPC2 mutant caused by a change of the first codon (p.M1L). The novel missense mutations were further investigated by two bioinformatics approaches. Panther proein classification system computationally predicted the detrimental effect of all new missense mutations occurring at evolutionary conserved positions. The other bioinformatics approach was based on prediction of structural alterations induced by missense mutations on the NPC1 atomic models. The in silico analysis predicted protein malfunctioning and/or local folding alteration for most missense mutations. Moreover, the effects of the missense mutations (p.Y634C, p.S636F, p.L648H, and p.V780G) affecting the sterol-sensing domain (SSD) were evaluated by docking simulation between the atomic coordinates of SSD model and cholesterol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252935     DOI: 10.1007/s10048-009-0175-3

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  44 in total

1.  Integrating computation and visualization for biomolecular analysis: an example using python and AVS.

Authors:  M F Sanner; B S Duncan; C J Carrillo; A J Olson
Journal:  Pac Symp Biocomput       Date:  1999

Review 2.  The NPC1 protein: structure implies function.

Authors:  Catherine Scott; Y A Ioannou
Journal:  Biochim Biophys Acta       Date:  2004-10-11

3.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; N Gazzah; M C Juge; P G Pentchev; A Revol; P Louisot
Journal:  Biochim Biophys Acta       Date:  1991-06-05

4.  Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein.

Authors:  Rodney E Infante; Lina Abi-Mosleh; Arun Radhakrishnan; Jarrod D Dale; Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2007-11-06       Impact factor: 5.157

5.  NPC1: Complete genomic sequence, mutation analysis, and characterization of haplotypes.

Authors:  Peter Bauer; Rupert Knoblich; Claudia Bauer; Ulrich Finckh; Antje Hufen; Julia Kropp; Silja Braun; Birgit Kustermann-Kuhn; Dörthe Schmidt; Klaus Harzer; Arndt Rolfs
Journal:  Hum Mutat       Date:  2002-01       Impact factor: 4.878

6.  Subclinical course of adult visceral Niemann-Pick type C1 disease. A rare or underdiagnosed disorder?

Authors:  L Dvorakova; J Sikora; M Hrebicek; H Hulkova; M Bouckova; L Stolnaja; M Elleder
Journal:  J Inherit Metab Dis       Date:  2006-06-26       Impact factor: 4.982

7.  Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.

Authors:  S Bertolini; A Cantafora; M Averna; C Cortese; C Motti; S Martini; G Pes; A Postiglione; C Stefanutti; I Blotta; L Pisciotta; M Rolleri; S Langheim; M Ghisellini; I Rabbone; S Calandra
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

8.  Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain.

Authors:  W L Greer; M J Dobson; G S Girouard; D M Byers; D C Riddell; P E Neumann
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

Review 9.  Niemann-Pick disease type C.

Authors:  M T Vanier; G Millat
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

Review 10.  Structure and function of the NPC2 protein.

Authors:  Marie T Vanier; Gilles Millat
Journal:  Biochim Biophys Acta       Date:  2004-10-11
View more
  17 in total

1.  Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking.

Authors:  Stefania Zampieri; Bruno Bembi; Natalia Rosso; Mirella Filocamo; Andrea Dardis
Journal:  JIMD Rep       Date:  2011-09-06

Review 2.  Miglustat: a review of its use in Niemann-Pick disease type C.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2014-01       Impact factor: 9.546

3.  The Spectrum of Niemann-Pick Type C Disease in Greece.

Authors:  Irene Mavridou; Evangelia Dimitriou; Marie T Vanier; Lluisa Vilageliu; Daniel Grinberg; Philippe Latour; Athina Xaidara; Lilia Lycopoulou; Sevasti Bostantjopoulou; Dimitrios Zafeiriou; Helen Michelakakis
Journal:  JIMD Rep       Date:  2017-01-20

4.  Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?

Authors:  Marta Molina Romero; Alberto Yoldi Chaure; Miguel Gañán Parra; Purificación Navas Bastida; José Luis Del Pico Sánchez; Ángel Vaquero Argüelles; Paloma de la Fuente Vaquero; Juan Pablo Ramírez López; José Antonio Castilla Alcalá
Journal:  J Assist Reprod Genet       Date:  2022-01-29       Impact factor: 3.412

Review 5.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

6.  Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease?

Authors:  Fiore Manganelli; Raffaele Dubbioso; Rosa Iodice; Antonietta Topa; Andrea Dardis; Cinzia Valeria Russo; Lucia Ruggiero; Stefano Tozza; Alessandro Filla; Lucio Santoro
Journal:  J Neurol       Date:  2014-02-26       Impact factor: 4.849

7.  Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts.

Authors:  Dana L Cruz; Nina Pipalia; Shu Mao; Deepti Gadi; Gang Liu; Michael Grigalunas; Matthew O'Neill; Taylor R Quinn; Andi Kipper; Andreas Ekebergh; Alexander Dimmling; Carlos Gartner; Bruce J Melancon; Florence F Wagner; Edward Holson; Paul Helquist; Olaf Wiest; Frederick R Maxfield
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-27

8.  Defining structural and evolutionary modules in proteins: a community detection approach to explore sub-domain architecture.

Authors:  Jose Sergio Hleap; Edward Susko; Christian Blouin
Journal:  BMC Struct Biol       Date:  2013-10-16

9.  Diagnosis of Niemann-Pick disease type C with 7-ketocholesterol screening followed by NPC1/NPC2 gene mutation confirmation in Chinese patients.

Authors:  Huiwen Zhang; Yu Wang; Na Lin; Rui Yang; Wenjuan Qiu; Lianshu Han; Jun Ye; Xuefan Gu
Journal:  Orphanet J Rare Dis       Date:  2014-06-10       Impact factor: 4.123

10.  Effects of miglustat treatment in a patient affected by an atypical form of Tangier disease.

Authors:  Annalisa Sechi; Andrea Dardis; Stefania Zampieri; Claudio Rabacchi; Paolo Zanoni; Sebastiano Calandra; Giovanna De Maglio; Stefano Pizzolitto; Valerio Maruotti; Antonio Di Muzio; Frances Platt; Bruno Bembi
Journal:  Orphanet J Rare Dis       Date:  2014-09-18       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.